RCUS
RCUS
NYSE · Biotechnology

Arcus Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$24.31
+0.19 (+0.79%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 14 78%
Hold 4 22%
Sell 0 0%
Price Target
Analyst Price Target +313.4% upside
Low Target $77.00
Average Target $100.50
High Target $121.27
Current Price $24.31
Current
$24.31
Target
$100.50
$77.00 $100.50 avg $121.27
Scenario Analysis
Bear Case
$77.00
216.7%
Low target
Base Case
$100.50
+313.4%
Avg target
Bull Case
$121.27
+398.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$28.72
-15.4% from high
52-Week Low
$7.91
+207.3% from low
50-Day SMA
$22.13
+9.9% vs SMA
200-Day SMA
$15.14
+60.6% vs SMA
RSI (14)
36.6
Neutral
Target vs 52W High
$100.50
+249.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%